Dr Bookes has extensive experience in the health and biotechnology industries, first becoming involved in the sector in the 1990s as a consultant.  He has since held board positions in numerous ASX listed biotechnology companies, including Chariman of genomics solutions company, RHS Ltd, which was acquired by PerkinElmer Inc (NYSE:PIK $9B biotech company) in June 2018. He is a Fellow of the Australian College of Rural and Remote Medicine and a Fellow of the AICD.